Header Logo

Connection

HESHAM MOHAMED to Myelodysplastic Syndromes

Back to Details
This is a "connection" page, showing publications HESHAM MOHAMED has written about Myelodysplastic Syndromes.
HESHAM MOHAMED
Connection Strength
0.189
Myelodysplastic Syndromes
  1. Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial. Lancet Haematol. 2023 Jan; 10(1):e46-e58.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.